Cystoid Macular Edema Following Cataract Surgery Clinical Trial
Official title:
Impact of Different Fluidic Parameters on Development of Cystoid Macular Edema Following Phacoemulsification
Verified date | June 2012 |
Source | Iladevi Cataract and IOL Research Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | India: Institutional Review Board |
Study type | Interventional |
Understanding and modulating fluid parameters is an important, but often overlooked aspect
of phacoemulsification. In a previous study we compared the impact of using high fluid
parameters versus low fluidic parameters on real-time IOP measured during
phacoemulsification. The investigators found that using high parameters resulted in a higher
absolute rise in IOP as well as higher fluctuations in the IOP when compared to low
parameters. Clinically these higher fluctuations in IOP would translate in a higher chamber
instability. Based on the results of this study, the investigators decided to take it
further and study the impact of using high parameters (and thus, higher chamber instability)
on macular edema and thickness following surgery, in an otherwise uncomplicated surgery.
Higher fluid parameters during phacoemulsification predisposes the eye to increased macular
thickness
Status | Completed |
Enrollment | 150 |
Est. completion date | August 2011 |
Est. primary completion date | February 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 40 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Uncomplicated, Age-related cataract. 2. Nuclear sclerosis: upto grade 3 3. Age: 40-70 years 4. Axial length: 21.5 mm to 24.5 mm Exclusion Criteria: 1. Diabetes mellitus 2. Co-existing ocular disease- uveitis, glaucoma, PEX 3. Pre-existing macular pathology (eg.ARMD) 4. Previously operated eyes 5. Under treatment with Topical or systemic steroids / NSAID's 6. Intraoperative complications- PCR, Descemet's detachment, uveal trauma 7. Post operative complications - severe inflammation (>grade 3), rise in IOP |
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
India | Raghudeep Eye Clinic | Ahmedabad | Gujarat |
Lead Sponsor | Collaborator |
---|---|
Iladevi Cataract and IOL Research Center |
India,
Bélair ML, Kim SJ, Thorne JE, Dunn JP, Kedhar SR, Brown DM, Jabs DA. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009 Jul;148(1):128-35.e2. doi: 10.101 — View Citation
Biro Z, Balla Z, Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye (Lond). 2008 Jan;22(1):8-12. Epub 2006 Jun 2. — View Citation
Cagini C, Fiore T, Iaccheri B, Piccinelli F, Ricci MA, Fruttini D. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery. Curr Eye Res. 2009 Dec;34(12):1036-4 — View Citation
Kim SJ, Belair ML, Bressler NM, Dunn JP, Thorne JE, Kedhar SR, Jabs DA. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina. 2008 Jun;28(6):870-6. doi: 10.1097/IAE.0b013e318169d04e. — View Citation
Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007 May;114(5):881-9. Epub 2007 Feb 1. — View Citation
Lee YC, Chung FL, Chen CC. Intraocular pressure and foveal thickness after phacoemulsification. Am J Ophthalmol. 2007 Aug;144(2):203-208. Epub 2007 May 30. — View Citation
Perente I, Utine CA, Ozturker C, Cakir M, Kaya V, Eren H, Kapran Z, Yilmaz OF. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res. 2007 Mar;32(3):241-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | cystoid macular edema (CME) | A > or = 30% increase in baseline central foveal thickness measaured by anterior segment OCT will be defined as having CME. | 3 months | Yes |
Secondary | macular thickness | macular thickness measured in 3 zones using the anterior segment OCT | 1, 3 months | Yes |
Secondary | central corneal thickness (CCT) | CCT will be measured on the ultrasound pachymeter by a single experienced observer | first post-operative day, | Yes |
Secondary | endothelial cell loss | Endothelial cell loss will be measured using a specular microscope in the central area by a single technician | 6 months post-operative | Yes |
Secondary | anterior chamber inflammation | it will be assessed on the slit lamp examination by a single experienced observer using the Hogan's criteria | 1 months | Yes |
Secondary | CORRECTED DISTANCE VISUAL ACUITY (CDVA) | visual acuity (VA) of 20/40 or worse was defined as "clinically significant" | 3 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01546402 -
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
|
Phase 4 | |
Completed |
NCT04940338 -
PCME Prevention in Patients With NPDR
|
Phase 4 | |
Completed |
NCT05811182 -
Vitreous Hyper Reflective Dots in Association With Pseudophakic Cystoid Macular Edema
|